Second Genome Company

Second Genome offers a pipeline of microbiome modulators that impact infection, immunity and metabolic diseases.
Technology: Anti-infective Drugs
Industry: PharmTech
Headquarters: San Francisco, California, United States
Founded Date: 2009
Employees Number: 11-50
Funding Status: Early Stage Venture
Estimated Revenue: $1M to $10M

Visit Website
info@secondgenome.com
http://twitter.com/SecondGenome
Register and Claim Ownership